Effect of infliximab on inflammatory and fibrous lesions in patients with intestinal Crohn's disease.
Phase of Trial: Phase IV
Latest Information Update: 02 Aug 2017
At a glance
- Drugs Infliximab (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- Acronyms ACTIF
- 02 Aug 2017 This trial has been Discontinued in UK , according to European Clinical Trials Database
- 10 Jun 2017 Biomarkers information updated
- 27 Jun 2012 Actual initiation date changed from 27 May 2008 to 22 Jun 2007 as reported by European Clinical Trials Database record.